Personalis, Inc.

NASDAQ:PSNL

Medical - Diagnostics & Research

Healthcare
$14.98 +3.44%

+$0.34 today

Market cap
$1.62B
Beta
2.28
P/E (TTM)
-11.0
EPS (TTM)
-$0.92
52W Low $3.84High $12.53

Volume 1.47M

Average 2.31M

PSNL Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Personalis, Inc.NASDAQ: PSNL

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 104.19M shares rose 19.1% year over year, behind the +36.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 12.9% from the prior quarter. Over 3 fiscal years it compounded at +25.0% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +19.1% toward the trailing-twelve-month pace of +36.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
104.19M+12.9% QoQ
Last fiscal yearDec 2025
89.24M+50.6% YoY
LTMMar 2026
93.42M+36.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.1%——
1 year+50.6%——
3-year CAGR+25.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
89.24M USD
Year-over-year change
+50.6%
4-year CAGR
+19.4%

Weighted Avg Shares vs competitors

How PSNL compares with its peers on the latest reported figures

  • PSNL's LTM Mar 2026 weighted avg shares of 93.42M shares is the 4th highest of the 10 companies compared; the peer median is 79.27M shares.
  • Its year-over-year change of +36.5% is the highest of 10, against a peer median of +2.4%.
  • Over three fiscal years its annual growth of +25.0% compares with a peer median of +5.4%.
PSNL Competitors Peer median
Weighted Avg Shares for PSNL and competitors
Company Period LTM YoY 3-year CAGR
NTRANatera, Inc.LTM Jun 2026139.67M +7.5%+11.6%
GHGuardant Health, Inc.LTM Sep 2026131.61M +6.0%+7.1%
NEONeoGenomics, Inc.LTM Jun 2026128.84M +1.3%+1.0%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
VCYTVeracyte, Inc.LTM Jun 202679.27M +2.0%+3.2%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
GRALGRAIL, Inc.LTM Jun 202640.15M +20.6%+5.8%
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +3.5%+38.0%
Peer median (excluding PSNL) 79.27M+2.4%+5.4%

Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue85.49M65.05M73.48M84.61M0
Cost of Revenue53.84M51.7M55.27M57.79M53.87M
Gross Profit31.66M13.35M18.21M26.83M(53.87M)
Gross Margin37.0%20.5%24.8%31.7%—
Research & Development49.31M64.91M64.78M48.91M50.26M
Selling, General & Admin47.7M63.97M49.73M46.19M53.57M
Operating Expenses97.01M128.88M128.14M95.09M34.19M
Depreciation & Amortization6.01M8.43M11.3M10.94M10.05M
EBITDA(59.01M)(104.64M)(96.81M)(70.3M)(71M)
EBITDA Margin-69.0%-160.9%-131.7%-83.1%—
Operating Income(65.35M)(115.53M)(109.94M)(68.27M)(88.06M)
Operating Margin-76.4%-177.6%-149.6%-80.7%—
Interest Income367K2.4M5.9M5.51M7.16M
Interest Expense184K201K110K24K205K
Other Income / Expenses141K2.26M1.72M(13M)6.81M
Income Before Tax(65.21M)(113.28M)(108.21M)(81.27M)(81.25M)
Pre-Tax Margin-76.3%-174.1%-147.3%-96.0%—
Income Tax Expense14K40K83K18K21K
Net Income(65.23M)(113.32M)(108.3M)(81.28M)(81.27M)
Net Margin-76.3%-174.2%-147.4%-96.1%—
EPS (Basic)(1.49)(2.48)(2.25)(1.37)(0.91)
EPS (Diluted)(1.49)(2.48)(2.25)(1.37)(0.91)
Weighted Avg Shares43.89M45.7M48.18M59.25M89.24M
Weighted Avg Shares (Diluted)43.89M45.7M48.18M59.25M89.24M

Personalis, Inc.

NASDAQ:PSNL

Intrinsic Alpha fair value

Locked

Current Price

$14.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.